PARP1 and cancer: Together, these data place PARPs at a shared mechanistic frontier of oncology and viral disease—coordinating DDR-derived innate sensing, immune evasion, and metabolic rewiring—and motivate the development of therapeutic strategies that co-target PARP/cGAS-STING and NAD+ metabolism in virus-associated cancers.